ENACT Trademark
ENACT is a USPTO trademark filed by INCYTE HOLDINGS CORPORATION. Status: Registered.
Trademark Facts
| Mark | ENACT |
|---|---|
| Serial Number | 88461015 |
| Registration Number | 6214070 |
| Status | Registered |
| Filing Date | 2019-06-05 |
| Registration Date | 2020-12-08 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | INCYTE HOLDINGS CORPORATION |
| Attorney of Record | Frances M. Jagla |
| Prosecution Events | 33 |
| Latest Event | REM1 on 2025-12-08 |
Goods & Services
Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of cancer; vaccine preparations for use in connection with cancer and oncology; antibodies sold as an ingredient of pharmaceuticals for the treatment of cancer; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines for use in connection with cancer and oncology; biological preparations for human medical diagnostics and analysis for use in the treatment of cancer; medical diagnostic reagents for use in connection with cancer and oncology; clinical medical reagents for use in connection with cancer and oncology; biological preparations for medical and veterinary purposes in connection with the treatment of cancer | Research and development in the pharmaceutical and biotechnology fields in connection with cancer and oncology; research and development of medicines in the fields of cancer and oncology; scientific and technological services and research and design services in the fields of cancer and oncology; biological research, clinical research and medical research in the fields of cancer and oncology; chemical and biochemical analysis services in the fields of cancer and oncology; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology in connection with cancer and oncology; clinical research in the fields of cancer and oncology; providing medical and scientific research information in the field of pharmaceuticals in connection with cancer and oncology; Research and development services in the field of antibodies for use in connection with cancer and oncology